Tag: CTO
Chronic total occlusions: Do we need to update the crossing algorithm?
This advertorial is sponsored by Bentley.
Complex peripheral chronic total occlusions (CTOs) represent a daily challenge for interventionalists, necessitating a standardised approach for optimal patient...
Real-world registry shows sustained efficacy for Eluvia DES in the SFA
This advertorial is sponsored by Boston Scientific.
During a satellite symposium session dedicated to real cases and trial outcomes which was held at the Cardiovascular...
Bentley and Cook Medical enter US distribution agreement for BeBack crossing...
Cook Medical and Bentley today announced a distribution agreement for the BeBack crossing catheter in the USA, with Cook assuming commercial responsibilities for the Bentley...
Ra Medical Systems reaches 100 enrolled subjects in pivotal atherectomy clinical...
Ra Medical Systems has announced the achievement of a milestone with the enrollment of 100 subjects in the pivotal clinical study, according to a...
BD launches new Crosser iQ CTO recanalisation system
BD has announced the launch and US Food and Drug Administration (FDA) 510(k) clearance for the Crosser iQ chronic total occlusion (CTO) recanalisation system,...
OUTBACK™ Elite Re-entry catheter highly effective at saving limbs in extreme...
Lorenzo Patrone (London, UK) shares with BLearning at CIRSE 2019 (7–11 September, Barcelona, Spain) the benefits of using the OUTBACK™ Elite Re-entry Catheter (Cordis,...
RD Global-Invamed receives CE mark to market Extender DCB and Temren...
RD Global-Invamed has announced it has received CE marking to market the Extender drug-coated balloon (DCB) and Temren atherectomy with CTO catheter for treating...
